ipilimumab [clinicaltrials_resource:21fc135eae630062456c292430b1e81a]
Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [clinicaltrials:NCT00025181]Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00032045]Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy [clinicaltrials:NCT00047164]Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer [clinicaltrials:NCT00057889]Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00058279]Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00077532]MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery [clinicaltrials:NCT00112580]Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma [clinicaltrials:NCT00357461]
intervention [clinicaltrials_vocabulary:intervention]
ipilimumab [clinicaltrials_resource:21fc135eae630062456c292430b1e81a]
Bio2RDF identifier
21fc135eae630062456c292430b1e81a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:21fc135eae630062456c292430b1e81a
intervention name [clinicaltrials_vocabulary:intervention-name]
ipilimumab
identifier
clinicaltrials_resource:21fc135eae630062456c292430b1e81a
title
ipilimumab
@en
type
label
ipilimumab [clinicaltrials_resource:21fc135eae630062456c292430b1e81a]
@en